CTI Life Sciences
CTI Life Sciences
Type of Funding
Venture Capital
Max Funding
N/A
Region
Federal/National
Application Difficuty
Fairly simple
Processing Time
Slow (A few months)
Province
All Of Canada
Industry
Health and other services.
Funding Goals
Start-up Funding.
Demographic
N/A
Incorporated
No
Contact
514 798 2333
Apply For A Loan
Business location – Canada
Monthly Revenue – $10K +
Time in Business – 6 months +
Funds in 24 hours
$10,000 to $800,000
Details
Based in Montréal, CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S.
CTI Life Sciences currently manage $245 million of assets.
Eligibility
Early stage investment
Similar funding programs
Venture Capital
Vanedge Capital is a Vancouver based early-stage venture capital fund investing in technology inflection points in cloud computing, artificial intelligence, cyber security, SaaS and digital media.
The Vanedge team helps entrepreneurs with a combination of deep technical expertise and cross-border operational experience to rapidly scale product development, marketing and sales.
Vanedge has over $296M in assets under management.
Max Funding N/A
Vanedge Capital
Venture Capital
Eventi Capital Partners (ECP) is a Toronto-based growth capital investment group, specializing in software-as-a-service, Internet infrastructure services and more recently medical devices.
Founded in 2002, Eventi Capital Partners leverages the extensive operational and investment experience of its Managing Partners to enable CEOs to scale their business more predictably.
They invest in passionate entrepreneurs who possess deep domain expertise and are committed to building a scalable company that delivers exceptional value to its customers.
Max Funding N/A
Eventi Capital Partners
Venture Capital
Purple Angel is a venture capital firm focused on investments in the communications and infrastructure sectors. It was formed in early 2001 by several retired alumni of Bell Northern Research (BNR).
Max Funding N/A
Purple Angel